Antibody-drug conjugates this novel approach represent a promising advancement in the battle with cancer. ADCs integrate the targeting ability of antibodies with the lethal force of cytotoxic drugs. By carrying these potent agents directly to malignant tissues , ADCs maximize treatment efficacy while reducing harm to healthy tissues . This targeted